Skin Elements Limited

—As of Sun 8 Nov 2026, 12:00 UTC

ASX:SKNConsumer Staples

Country Australia

PE (Fwd) •••

TSR 10Y CAGR (35.31%)

Div yield —

ROE —

Household & Personal Products

Beta (5Y) (0.57)

PE TTM —

TSR TTM (66.67%)

Mkt cap A$6.983M

ROIC —

SE Grade™

Value

Quality

Moat

Consensus

Reference

$0.002

1.48%

(91.69%)

Hold 2|1|12|0|12

TTM

FYE 30 Jun AUD

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

5Y

10Y

Peers

0.757

Revenue$M

1.276

1.352

1.416

1.515

1.601

1.705

1.847

1.991

2.108

2.230

0.775

6.86%

6.30%

21

10.46

Revenue growth%

14.61

16.12

15.94

17.04

19.50

18.95

20.27

18.54

16.75

19.45

16.44

18.95

17.79

47

27.74

Gross margin%

12.10

9.58

11.79

12.55

12.38

10.47

13.26

15.90

15.66

13.83

17.82

13.83

12.47

81

11.15

Operating margin%

9.48

7.19

5.51

6.24

4.97

2.03

5.01

7.32

8.28

7.49

4.51

7.32

6.72

73

17.41

Net margin%

6.09

4.39

2.89

1.79

1.74

2.21

4.93

3.94

6.82

7.74

18.01

4.93

4.16

13

18.45

P/E ratio (avg)x

41.98

42.17

41.11

46.80

53.73

51.58

57.99

53.68

57.95

63.31

18.97

57.95

52.63

87

15.60

EV/EBITx

32.68

31.23

31.76

31.89

26.99

24.58

21.74

18.51

18.84

20.39

36.71

20.39

25.79

79

17.50

FCF yield (avg)%

25.37

24.28

23.21

25.84

25.86

27.06

26.74

27.08

26.59

27.64

4.25

27.06

26.22

46

16.50

FCF margin%

24.38

22.30

22.11

22.42

22.48

23.01

24.68

22.59

23.49

24.27

18.59

23.49

22.80

38

0.905

FCF / Net incomex

2.122

2.102

2.275

2.201

2.432

2.296

2.410

2.262

2.509

2.535

0.760

2.410

2.285

11

4.80

ROIC%

25.39

28.16

26.85

25.98

27.95

29.19

27.48

26.68

25.67

24.95

10.29

26.68

26.76

24

18.41

Return on equity%

29.07

29.27

28.99

30.74

33.12

33.34

33.60

35.57

36.70

33.93

29.27

33.93

33.23

14

21.05

Return on assets%

13.27

12.51

13.77

14.63

17.08

14.88

15.84

13.28

11.78

10.04

2.98

13.28

13.53

89

—

EPS$

—

—

—

—

—

—

—

—

—

—

—

(3.26%)

0.05%

—

13.81

EPS growth%

0.40

0.40

0.40

3.01

3.61

2.36

1.42

2.94

2.79

5.23

23.00

2.79

2.58

60

—

Bookvalue per sh$

—

—

—

—

—

—

—

—

—

—

—

(0.03%)

3.18%

—

—

FCF per share$

—

—

—

—

—

—

—

—

—

—

—

3.87%

2.38%

—

—

Dividend per sh$

—

—

—

—

—

—

—

—

—

—

—

(1.74%)

(2.63%)

—

2.05

Div yield (avg)%

7.21

9.55

12.10

12.19

14.27

16.69

19.66

22.14

19.80

18.24

17.25

19.66

15.48

77

25.23

Payout ratio%

10.23

8.34

10.76

10.50

11.56

11.25

9.87

7.03

8.14

5.28

5.53

8.14

10.05

68

3.591

Shares (diluted)B

4.608

4.598

4.503

5.367

5.671

6.242

6.944

7.429

7.884

9.460

3.414

10.78%

9.45%

92

5.69

Buyback yield%

2.28

1.07

0.40

0.40

0.40

0.92

1.10

1.63

0.55

0.40

17.98

0.92

0.74

26

0.566

D/E ratiox

2.054

2.032

2.030

2.168

2.534

2.661

2.913

3.321

3.893

3.969

1.315

3.321

2.597

24

0.529

Enterprise value$M

0.230

0.265

0.258

0.290

0.277

0.311

0.359

0.416

0.448

0.486

0.135

11.89%

9.08%

82

1.303

LT debt$M

0.472

0.462

0.487

0.585

0.626

0.642

0.661

0.697

0.831

0.888

1.137

7.26%

8.36%

38

Peers (US$4.796M)

Cap (US$)

PE

Zoono Group Limited

10.77M

—

Anagenics Limited

4.061M

15.04x

Prestal Holdings…

2.693M

—

Instinct Bio Technical…

5.038M

—

Capital

TTM

5Y

10Y

Leveragex

0.193

0.119

0.088

EBIT/Intx

0.598

0.983

0.959

Own earn%

(84.42)

98.45

91.75

Sh yield%

7.74

20.36

16.14

Owners

Insiders/Inst%

7.24

20.95

Short interest%

4.35

SBC / revenue%

2.41

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

22

Op margin range%

2–9

$1 testx

—

Incr. ROIC%

11

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

$2.230M

6.30%

1.00×

Cost of revenue

$0.995M

6.32%

1.00×

Operating expenses

$0.484M

6.16%

0.99×